Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
10.18
+0.31 (3.14%)
At close: Dec 12, 2025, 4:00 PM EST
9.98
-0.20 (-1.96%)
After-hours: Dec 12, 2025, 7:05 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $798.55 million as of December 12, 2025. Its market cap has decreased by -26.29% in one year.
Market Cap
798.55M
Enterprise Value
551.23M
1-Year Change
-26.29%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $798.55M, an increase of 70.81%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 798.55M | -14.31% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 245.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |